Skip to main content

Advertisement

SpringerLink
Log in

A Move to Conservativism in Pediatric Urology

  • Surgical (J Karpelowsky, Section Editor)
  • Published:
Current Pediatrics Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To define the evidence on the move to conservative treatment in four areas of pediatric urology: laparoscopic ureteric clipping in non-functioning duplex kidney, management of multicystic dysplastic kidney (MCDK), intravesical botulinum toxin injection in detrusor over activity, and risk stratification of gonadal tumors in disorders of sexual development.

Recent Findings

Laparoscopic ureteric clipping has been validated in one preliminary study. Lesser investigation and non-operative management of MCDK has been validated. An increasing body of evidence showing botulinum toxin injection can effectively treat detrusor over activity and reduce the need for bladder augmentation. New data on testicular biopsy can now identify patients at risk of germ cell tumor and reduce need for gonadectomy.

Summary

Pediatric urology is shifting to less invasive management in a number of common conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Jayram G, Roberts J, Hernandez A, Heloury Y, Manoharan S, Godbole P, LeClair M, Mushtaq I, Gundeti MS. Outcomes and fate of the remnant moiety following laparoscopic heminephrectomy for duplex kidney: a multicenter review. J Pediatr Urol. 2011;7(3):272–5.

    Article  CAS  PubMed  Google Scholar 

  2. Gallentine ML, Wright Jr FH. Ligation of the native ureter in renal transplantation. J Urol. 2002;167(1):29–30.

    Article  PubMed  Google Scholar 

  3. •• Romao RL, Figueroa V, Salle JL, Koyle MA, Bägli DJ, Lorenzo AJ. Laparoscopic ureteral ligation (clipping): a novel, simple procedure for pediatric urinary incontinence due to ectopic ureters associated with non-functioning upper pole renal moieties. J Pediatr Urol. 2014;10(6):1089–94. This is the defining publication on the technique of laparoscopic ureteric ligation in the setting of upper pole moieties in children.

    Article  CAS  PubMed  Google Scholar 

  4. Feldenberg LR, Siegel NJ. Clinical course and outcome for children with multicystic dysplastic kidneys. Pediatr Nephrol. 2000;14:1098–101.

    Article  CAS  PubMed  Google Scholar 

  5. Rudnik-Schoneborn S, John U, Deget F, Ehrich JH, Misselwitz J, Zerres K. Clinical features of unilateral multicystic renal dysplasia in children. Eur J Pediatr. 1998;157:666–72.

    Article  CAS  PubMed  Google Scholar 

  6. •• Whittam BM, Calaway A, Szymanski KM, Carroll AE, Misseri R, Kaefer M, Rink RC, Karmazyn B, Cain MP. Ultrasound diagnosis of multicystic dysplastic kidney: is a confirmatory nuclear medicine scan necessary? J Pediatr Urol. 2014;10(6):1059–62. This study validates the use of ultrasound alone to confirm the diagnosis of multicystic dysplastic kidney .

    Article  PubMed  Google Scholar 

  7. Ismaili K, Avni FE, Alexander M, Schulman C, Collier F, Hall M. Routine voiding cystourethrography is of no value in neonates with unilateral multicystic dysplastic kidney. J Pediatr. 2005;146(6):759–63.

    Article  PubMed  Google Scholar 

  8. Hains DS, Bates CM, Ingraham S, Schwaderer AL. Management and etiology of the unilateral multicystic dysplastic kidney: a review. Pediatr Nephrol. 2009;24(2):233–41.

    Article  PubMed  Google Scholar 

  9. Narchi H. Risk of hypertension with multicystic kidney disease: a systematic review. Arch Dis Child. 2005;90(9):921–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Homsy YL, Anderson JH, Oudjhane K, Wilms RP. Tumor and multicystic dysplastic kidney disease. J Urol. 1997;158(6):2256–9.

    Article  CAS  PubMed  Google Scholar 

  11. Narchi H. Risk of Wilms’ tumour with multicystic kidney disease: a systematic review. Arch Dis Child. 2005;90(2):147–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. •• Eickmeyer AB, Casanova NF, He C, Smith EA, Wan J, Bloom DA, Dillman JR. The natural history of the multicystic dysplastic kidney–is limited follow-up warranted? J Pediatr Urol. 2014;10(4):655–61. This study proposes a follow-up algorithm for multicystic dysplastic kidney involving a much reduced burden on ultrasound and tertiary service follow-up without complication.

    Article  CAS  PubMed  Google Scholar 

  13. Hsieh PF, Chiu HC, Chen KC, Chang CH, Chou EC. Botulinum toxin A for the treatment of overactive bladder. Toxins (Basel). 2016;8(3).

  14. Schurch B, Stöhrer M, Kramer G, Schmid DM, Gaul G, Hauri D Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results J Urol 2000;164(3 Pt 1):692–697.

  15. Schulte-Baukloh H, Michael T, Schobert J, Stolze T, Knispel HH. Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. Urology. 2002;59(3):325–7. discussion 327-8

    Article  CAS  PubMed  Google Scholar 

  16. Kask M, Rintala R, Taskinen S. Effect of onabotulinumtoxinA treatment on symptoms and urodynamic findings in pediatric neurogenic bladder. J Pediatr Urol. 2014;10(2):280–3.

    Article  CAS  PubMed  Google Scholar 

  17. •• Figueroa V, Romao R, Pippi Salle JL, Koyle MA, Braga LH, Bägli DJ, Lorenzo AJ. Single-center experience with botulinum toxin endoscopic detrusor injection for the treatment of congenital neuropathic bladder in children: effect of dose adjustment, multiple injections, and avoidance of reconstructive procedures. J Pediatr Urol. 2014;10(2):368–73. This important study highlights the improvement in symptoms and urodynamic parameters in patients with neurogenic bladder and also a cohort of patients that avoided surgical reconstruction as a result.

    Article  CAS  PubMed  Google Scholar 

  18. • Léon P, Jolly C, Binet A, Fiquet C, Vilette C, Lefebvre F, Bouché-Pillon-Persyn MA, Poli-Mérol ML. Botulinum toxin injections in the management of non-neurogenic overactive bladders in children. J Pediatr Surg. 2014;49(9):1424–8. This paper details the significant improvement in day and night incontinence and urodynamic parameters in non-neurogenic bladder.

    Article  PubMed  Google Scholar 

  19. • Greer T, Abbott J, Breytenbach W, McGuane D, Barker A, Khosa J, Samnakay N. Ten years of experience with intravesical and intrasphincteric onabotulinumtoxinA in children. J Pediatr Urol. 2016;12(2):94.e1–6. This report highlights the long-term benefit obtained from botulinum toxin in both neurogenic and non-neurogenic bladder.

    Article  CAS  Google Scholar 

  20. Nitii V. Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art Rev Urol. 2006 Fall; 8(4): 198–208

  21. Gamé X, Mouracade P, Chartier-Kastler E, Viehweger E, Moog R, Amarenco G, Denys P, De Seze M, Haab F, Karsenty G, Kerdraon J, Perrouin-Verbe B, Ruffion A, Soler JM, Saussine C. Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. J Pediatr Urol. 2009;5(3):156–64.

    Article  PubMed  Google Scholar 

  22. Looijenga LH, Hersmus R, de Leeuw BH, Stoop H, Cools M, Oosterhuis JW, Drop SL, Wolffenbuttel KP. Gonadal tumours and DSD. Best Pract Res Clin Endocrinol Metab. 2010;24(2):291–310.

    Article  PubMed  Google Scholar 

  23. Lee PA, Houk CP, Ahmed SF, Hughes IA; International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Pediatric Endocrinology. Consensus statement on management of intersex disorders.. Pediatrics 2006;118(2):e488–e500.

  24. Virtanen HE, Bjerknes R, Cortes D, Jørgensen N, Rajpert-De Meyts E, Thorsson AV, Thorup J, Main KM. Cryptorchidism: classification, prevalence and long-term consequences. Acta Paediatr. 2007;96(5):611–6.

    Article  PubMed  Google Scholar 

  25. Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med. 2007;356(18):1835–41.

    Article  CAS  PubMed  Google Scholar 

  26. Chung JM. Lee SD individualized treatment guidelines for Postpubertal cryptorchidism. World J Mens Health. 2015;33(3):161–6.

    Article  PubMed  PubMed Central  Google Scholar 

  27. •• Abacı A, Çatlı G, Berberoğlu M. Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development. Pediatr Endocrinol Metab. 2015;28(9–10):1019–27. Broad review of recent data on malignancy risk in DSD and timing of gonadectomy .

    Google Scholar 

  28. •• Faure A, Bouty A, O'Brien M, Thorup J, Hutson J, Heloury Y. Testicular biopsy in prepubertal boys: a worthwhile minor surgical procedure? Nat Rev Urol. 2016;13(3):141–50. This review details the histochemical markers used in testicular biopsy to stratify risk for germ cell tumours .

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Royal Children’s Hospital, Parkville, Melbourne, 3052, Australia

    Hemal Kodikara, Aurore Bouty, Mike O’Brien & Yves Heloury

Authors
  1. Hemal Kodikara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aurore Bouty
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mike O’Brien
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yves Heloury
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hemal Kodikara.

Ethics declarations

Conflict of Interest

Hemal Kodikara, Aurore Bouty, Mike O’Brien, and Yves Heloury each declare no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Surgical

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kodikara, H., Bouty, A., O’Brien, M. et al. A Move to Conservativism in Pediatric Urology. Curr Pediatr Rep 5, 176–181 (2017). https://doi.org/10.1007/s40124-017-0125-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40124-017-0125-8

Keywords

Search

Navigation